RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      Infectious microecology : theory and applications

      한글로보기

      https://www.riss.kr/link?id=M14454068

      • 저자
      • 발행사항

        Hangzhou : Zhejiang University Press ; Berlin : Springer, 2014

      • 발행연도

        2014

      • 작성언어

        영어

      • 주제어
      • DDC

        616.9041 판사항(23)

      • ISBN

        9783662438824
        3662438828
        9783662438831 (eBook)
        3662438836 (eBook)

      • 자료형태

        단행본(다권본)

      • 발행국(도시)

        중국 (본토)

      • 서명/저자사항

        Infectious microecology : theory and applications / Lanjuan Li, editor

      • 형태사항

        xxvii, 650 pages : illustrations (some color) ; 24 cm

      • 총서사항

        Advanced topics in science and technology in China = 1995-6819 Advanced topics in science and technology in China, 1995-6819

      • 일반주기명

        Includes bibliographical references and index

      • 소장기관
        • 국립중앙도서관 국립중앙도서관 우편복사 서비스
      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      목차 (Table of Contents)

      • CONTENTS
      • 1 Infectious Microecology = 1
      • 1.1 Conception of Infectious Microecology = 2
      • 1.1.1 Definition = 2
      • 1.1.2 Classification of Normal Microbiota α = 2
      • CONTENTS
      • 1 Infectious Microecology = 1
      • 1.1 Conception of Infectious Microecology = 2
      • 1.1.1 Definition = 2
      • 1.1.2 Classification of Normal Microbiota α = 2
      • 1.2 History of Infectious Microecology = 5
      • 1.2.1 The Embryonic Stage of Microecology = 5
      • 1.2.2 The Lag Phase of Microecology = 6
      • 1.2.3 The Developmental Stage of Microecology = 6
      • 1.2.4 The Establishment and Development of Infectious Microecology = 7
      • 1.3 The Subject Characteristics of Infectious Microecology = 8
      • 1.3.1 Subject Relations = 8
      • 1.3.2 Subject Core = 9
      • 1.3.3 Infectious Microecology Is a Basic Subject = 9
      • 1.3.4 Infectious Microecology Is an Applied Subject = 10
      • 1.4 The Classification of Infection = 11
      • 1.4.1 Types of Infection = 11
      • 1.4.2 The Evolution of Infection = 13
      • 1.4.3 The Outcome of Infection = 13
      • 1.5 Microecological Characteristics of Infection = 13
      • 1.5.1 Microecology Helps to Build and Maintain the Host's Immune Systems = 14
      • 1.5.2 Dynamic Balances between Microecology and Host = 15
      • 1.5.3 Many Infections are Correlated with Microecological Imbalance = 15
      • 1.6 The Microecological Mechanism of Infection = 16
      • 1.6.1 Occurrence of Infection = 16
      • 1.6.2 Development of Infection = 17
      • 1.6.3 Outcome of Infection = 17
      • 1.7 Prevention and Control of Infections Using Infectious Microecology Theories = 18
      • 1.7.1 The Revolution in Infection Prevention and Control Strategy = 18
      • 1.7.2 Mechanisms for Preventing and Controlling Infections with Microecological Modulators = 19
      • 1.7.3 Frequently Used Microecological Modulators = 19
      • 1.7.4 Prospects of Infection Prevention and Control Using Infectious Microecology Theories = 19
      • References = 20
      • 2 Human Microbiota and Its Function = 23
      • 2.1 Metabolic Functions = 24
      • 2.2 Trophic Functions = 27
      • 2.3 Interaction between Gut Bacteria and Host Immunity = 27
      • 2.4 Protective Functions : The Barrier Effect = 28
      • References = 29
      • 3 Infectious Microecology and Immunology = 33
      • 3.1 Infection and Immunity = 33
      • 3.1.1 Immunity Response to Microbes = 34
      • 3.1.2 Immune Responses to Extracellular Bacteria = 34
      • 3.1.3 Immune Responses to Intracellular Bacteria = 35
      • 3.1.4 Immune Responses to Fungi = 36
      • 3.2 Infectious Microecology and Immunology = 36
      • 3.2.1 Intestinal Microbes and Intestinal Barrier = 37
      • 3.2.2 Intestinal Microecology and Host Immunity = 39
      • 3.3 Hepatic Microecology and Immunity = 42
      • 3.3.1 Liver Involvement in Innate Immunity = 42
      • 3.3.2 Liver Involvement in Adaptive Immunity = 45
      • 3.4 Liver's Immune Privilege = 46
      • References = 49
      • 4 Microecology Disturbance and Infection = 59
      • 4.1 Microecology Disturbance = 59
      • 4.1.1 Concept of Microecology Disturbance = 60
      • 4.1.2 Classification of Microecology Disturbance = 60
      • 4.1.3 Influencing Factors of Microecology Disturbance = 64
      • 4.2 Infection = 68
      • 4.2.1 The Concept of Infection = 69
      • 4.2.2 Types of Infection = 70
      • 4.2.3 Etiologic Agent of Infection = 71
      • 4.2.4 Epidemic Links of Infection = 74
      • 4.3 The Relation between Microecology Disturbance and Infection = 75
      • 4.3.1 Traditional Biological Pathogeny Theory = 76
      • 4.3.2 Ecological Pathogeny Theory = 76
      • 4.3.3 The Significance of Infection = 76
      • 4.3.4 Microdysbiosis Induces Infection Diseases = 78
      • 4.3.5 Mechanism of Microorganisms and Host = 79
      • References = 80
      • 5 Nosocomial Infections and Bacterial Resistance = 83
      • 5.1 Nosocomial Infections = 84
      • 5.1.1 Introduction = 84
      • 5.1.2 Epidemiology of Nosocomial Infections = 85
      • 5.1.3 Pathogens of Nosocomial Infections = 89
      • 5.1.4 Common Nosocomial Infections = 91
      • 5.1.5 Prevention of Nosocomial Infections = 99
      • 5.2 Bacterial Resistance = 103
      • 5.2.1 Prevalence of Bacterial Resistance = 103
      • 5.2.2 Mechanisms of Bacterial Resistance = 110
      • 5.2.3 Strategies to Control Bacterial Resistance = 124
      • References = 124
      • 6 Microbial Culture and Its Clinical Application = 133
      • 6.1 Conventional Microbial Culture and Clinical Application = 133
      • 6.1.1 Clinical Blood Culture = 133
      • 6.1.2 Clinical Body Fluids Culture = 135
      • 6.1.3 Clinical Urine Culture = 136
      • 6.1.4 Culture of Specimens from Gastrointestinal Tract = 137
      • 6.2 Requirements for Collection of Cultural or Non-Cultural Specimens = 137
      • 6.2.1 Conventional Principles for Collection and Transportation of Specimens Used for Culture = 137
      • 6.2.2 Special Conditions for Collecting Specimens Used for 'Non-Routine' Culture = 139
      • 6.2.3 Inoculating Samples in an Optimal Media : Selection of the Culture Media = 140
      • 6.3 Clinical Choice of Microbial Culture or Non-Culture = 142
      • 6.3.1 Overview of Microbial Culture and Non-Culture Based Methods = 142
      • 6.3.2 Clinical Indication of Microbial Culture and Non-Culture = 144
      • 6.4 Interpretation of the Microbial Culture Results = 146
      • 6.4.1 Interpreting the Positive Results of the Microbial Culture = 147
      • 6.4.2 Interpreting the Negative Results of the Microbial Culture = 149
      • References = 150
      • 7 Molecular Microecological Techniques = 153
      • 7.1 Introduction = 154
      • 7.2 Size Pattern Analysis - T-RFLP Polymorphism Analysis of 16S rRNA Genes = 156
      • 7.3 Melting Pattern Analysis - PCR-DGGE Analysis of 16S rRNA Genes = 159
      • 7.4 FISH = 165
      • 7.5 Microarray Applications in Microbial Ecology Research = 168
      • 7.6 Cloning Library Construction and Sequencing = 172
      • 7.7 Next-Generation Sequencing Techniques for Microbial Ecology Research = 174
      • 7.8 Conclusion = 180
      • References = 180
      • 8 Metabonomic Phenotyping for the Gut Microbiota and Mammal Interactions = 189
      • 8.1 Mammals Are 'Superorganisms' = 189
      • 8.2 Co-Metabolisms and the Mammal-Microbiome Interactions = 190
      • 8.3 Metabonomic Phenotyping for Mammals = 191
      • 8.4 Future Perspectives = 194
      • References = 194
      • 9 Bioinformatics for Genomes and Metagenomes in Ecology Studies = 203
      • 9.1 Introduction to Advances in Microbial Ecology = 203
      • 9.2 16S rDNA in Ecology Studies = 204
      • 9.3 16S rDNA Gene Analysis = 205
      • 9.4 Metagenomics = 207
      • 9.5 Recent Applications of Environmental Metagenomic Sequencing = 208
      • 9.6 Analysis of Viral Communities = 209
      • 9.7 Assembly of Sequence Data = 209
      • 9.8 Assembly : Strategies = 211
      • 9.9 Assembly : Future Directions = 212
      • 9.10 Fragment Recruitment = 215
      • 9.11 Taxonomic Classification = 216
      • 9.12 MGTAXA = 216
      • 9.13 High Performance Computing = 217
      • 9.14 Functional Annotation = 218
      • 9.15 Analysis of Eukaryotes in Ecology Studies = 218
      • 9.16 Challenges Presented by Data Volume(Computational and Storage Requirements, Cloud Computing Solutions) = 219
      • 9.17 Future Directions = 221
      • References = 222
      • 10 Ecology of Oral Infectious Diseases = 227
      • 10.1 Ecological Basis = 228
      • 10.1.1 Oral Biotic Area = 229
      • 10.1.2 Normal Oral Microflora = 231
      • 10.1.3 Saliva and Dental Plaque Biofilm = 244
      • 10.2 Oral Infectious Diseases = 253
      • 10.2.1 Dental Caries = 253
      • 10.2.2 Pulpal and Periapical Diseases = 267
      • 10.2.3 Periodontal Disease = 273
      • 10.2.4 Maxillofacial Infectious Diseases = 285
      • 10.2.5 Oral Mucosal Infections = 287
      • 10.2.6 Secondary Infection from the Wearing of Dentures = 290
      • References = 291
      • 11 Gastrointestinal Infectious Microecology = 293
      • 11.1 Microbiota in Health = 293
      • 11.1.1 Normal Microbiota in the Stomach = 293
      • 11.1.2 Normal Microbiota in the Intestine = 294
      • 11.1.3 Physiological Functions of Gastrointestinal Microbiota = 295
      • 11.1.4 Factors Affecting Gastrointestinal Microecological Balance of the Host = 296
      • 11.2 Helicobacter Pylori and Gastroduodenal Disease = 298
      • 11.2.1 Helicobacter Pylori and Chronic Gastritis = 298
      • 11.2.2 Helicobacter Pylori and Peptic Ulcer = 298
      • 11.2.3 Helicobacter Pylori and Gastric Cancer = 299
      • 11.2.4 Diagnosis for H. Pylori Infection = 299
      • 11.2.5 Treatment = 301
      • 11.3 Inflammatory Bowel Disease = 301
      • 11.3.1 Role of Microbiota = 301
      • 11.3.2 Immune Response = 302
      • 11.3.3 Clinical Findings and Diagnosis = 302
      • 11.3.4 Treatment = 303
      • 11.4 Infectious Diarrhea = 304
      • 11.4.1 Diarrhea Caused by Toxins = 304
      • 11.4.2 Diarrhea Caused by Invasive Pathogens = 305
      • 11.4.3 Diarrhea Caused by Viruses = 305
      • 11.4.4 Diagnosis = 305
      • 11.4.5 Treatment = 306
      • 11.5 Irritable Bowel Syndrome = 306
      • 11.5.1 Etiology = 307
      • 11.5.2 Clinical Findings and Diagnosis = 308
      • 11.5.3 Treatment = 309
      • 11.6 Antibiotic-Associated Diarrhea = 309
      • 11.6.1 Pathogenesis = 309
      • 11.6.2 Clinical Findings and Diagnosis = 310
      • 11.6.3 Treatment = 311
      • 11.7 Colorectal Cancer = 311
      • 11.7.1 Pathogenesis = 312
      • 11.7.2 Symptoms = 313
      • 11.7.3 Diagnosis = 313
      • 11.7.4 Treatment = 314
      • 11.8 Gastrointestinal Tuberculosis = 314
      • References = 315
      • 12 Infectious Microecology in Liver Disease = 317
      • 12.1 An Overview of Infectious Microecology in Liver Disease = 318
      • 12.1.1 Liver Anatomy and Enterohepatic Recycling = 318
      • 12.1.2 Gut-Liver Axis = 318
      • 12.1.3 The Role of Kupffer Cells in Liver Disease = 319
      • 12.1.4 Endotoxin Activates Kupffer Cells in Liver Disease = 319
      • 12.1.5 Pathogenesis of Bacterial Translocation in Liver Disease = 321
      • 12.2 Gut Microflora in the Pathogenesis of the Complications of Cirrhosis = 322
      • 12.2.1 Bacterial Infections in Cirrhosis = 323
      • 12.2.2 Sources and Types of Bacterial Infection in Cirrhosis = 323
      • 12.2.3 Bacteria Translocation in the Pathogenesis of Spontaneous Bacterial Peritonitis in Cirrhosis = 324
      • 12.2.4 Gut Flora and the Hyperdynamic Circulatory State in Cirrhosis = 324
      • 12.2.5 The Gut Flora and Hepatic Encephalopathy = 325
      • 12.3 Modulation of Intestinal Microbiota as a Therapeutic Strategy of Liver Disease = 326
      • 12.3.1 Manipulation of Gut Flora and Its Effect on Infections in Cirrhosis = 326
      • 12.3.2 Manipulation of Gut Flora and Its Effect on Infections in Liver Transplants = 329
      • References = 329
      • 13 Biliary Infection, Pancreatic Infection and Microecology = 333
      • 13.1 Biliary Infection and Microecology = 333
      • 13.1.1 Microecology Foundation of Biliary Tract System = 334
      • 13.1.2 Biliary Infection and Microecology = 338
      • 13.1.3 Microecology Treatment of Biliary Tract Infection = 343
      • 13.2 Pancreatic Infection and Microecology = 349
      • 13.2.1 Microecology Foundation of the Pancreas = 350
      • 13.2.2 Pancreatic Infection and Microecology = 351
      • 13.2.3 Microecology Therapies for Pancreatic Infection = 359
      • References = 367
      • 14 Infectious Microecology in Urinary Tract and Reproductive System = 377
      • 14.1 Introduction = 377
      • 14.2 Infections of the Urinary Tract = 378
      • 14.2.1 Definitions = 378
      • 14.2.2 Classification = 379
      • 14.3 Diagnosis = 380
      • 14.3.1 Upper Urinary Tract Infection(UUTI) = 381
      • 14.3.2 Lowerr Urinaru Tract Infections(LUTI) = 390
      • 14.3.3 Factors Increasing Morbidity and/or Mortality = 395
      • 14.4 Prostatitis and Related Disorders = 396
      • 14.4.1 Epidemiology = 397
      • 14.4.2 Pathophysiology = 398
      • 14.4.3 Clinical Presentation and Diagnostic Evaluation = 398
      • 14.4.4 Causative Pathogens in Prostatitis = 399
      • 14.4.5 Treatment of Bacterial Prostatitis = 400
      • 14.4.6 Conclusions = 403
      • References = 403
      • 15 Infectious Microecology in the Diseases of the Respiratory System = 411
      • 15.1 Ecological Space and Microecological Characteristics of the Respiratory System = 411
      • 15.1.1 Non-Specific Defense Mechanism = 411
      • 15.1.2 Specific Defense Mechanism = 413
      • 15.2 Microecology and Microecology Changes in Respiratory System Infection = 414
      • 15.3 Microecology of Respiratory System Fungal Infection = 416
      • 15.3.1 Pulmonary Candidiasis = 416
      • 15.3.2 Pulmonary Aspergillosis = 417
      • 15.3.3 Pulmonary Cryptococcosis = 417
      • 15.3.4 Pulmonary Coccidioidomycosis = 418
      • 15.4 Microecology of Respiratory System Viral Infection = 418
      • 15.5 Microecology of Respiratory System Mycobacterial Infection = 419
      • 15.5.1 Pulmonary Tuberculosis = 420
      • 15.5.2 Non-Tuberculous Mycobacterial Disease = 424
      • 15.6 Main Measures of Microecological Prevention/Treatment and Respiratory System Ecological Prevention/Treatment in Anti-Infective Therapy = 426
      • References = 428
      • 16 Infectious Microecology of Skin = 431
      • 16.1 Histological Structures of Skin = 431
      • 16.1.1 Epidermis = 432
      • 16.1.2 The Dermis = 433
      • 16.1.3 Subcutaneous Tissue = 434
      • 16.1.4 Cutaneous Appendages : The Adnexa = 434
      • 16.2 Functions of Skin = 436
      • 16.2.1 Biological Barrier Function of Skin = 436
      • 16.2.2 Immune Function of Skin = 437
      • 16.2.3 Functions of the Sweat Gland and Sebaceous Gland = 439
      • 16.2.4 Nutritional Metabolism of Skin = 441
      • 16.2.5 Thermo-Regulation of Skin = 442
      • 16.3 Characteristics of Cutaneous Microecology = 443
      • 16.3.1 Normal Microbial Community of the Skin = 443
      • 16.3.2 Influential Factors of Cutaneous Normal Microflora = 448
      • 16.3.3 Physiological Function of Normal Cutaneous Microfloras = 454
      • 16.4 Microecological Disturbance and Cutaneous Disorders = 455
      • 16.4.1 Bacteria and Cutaneous Diseases = 455
      • 16.4.2 Fungi and Cutaneous Diseases = 457
      • 16.4.3 Virus and Cutaneous Diseases = 463
      • 16.4.4 Warts = 466
      • 16.5 Ecological Prevention and Treatment of Cutaneous Diseases = 468
      • 16.5.1 Protect the Macroecological Environment = 468
      • 16.5.2 Improve the Microecological Environment = 468
      • 16.5.3 Use Antibiotics Appropriately = 470
      • 16.5.4 Apply the Microecological Reagents = 470
      • 16.6 Prospects = 473
      • References = 474
      • 17 Infectious Microecology of the Hematological System = 477
      • 17.1 Defensive Function of Blood = 477
      • 17.1.1 Cellular Components of Blood = 478
      • 17.1.2 Non-Cellular Components of Blood = 479
      • 17.2 Molecular Ecology and Hematological Disease = 480
      • 17.2.1 Apoptosis and Hematological Disease = 481
      • 17.2.2 Oncogenes, Tumor Suppressor Genes and Signal Conducting Molecules = 487
      • 17.2.3 TelomereTelomerase = 491
      • 17.3 Microecological Changes and Hematologic Diseases = 493
      • 17.3.1 Helicobacter Pylori and Primary Gastric Lymphoma = 493
      • 17.3.2 Microecological Changes and Erythrocyte Disorders = 495
      • 17.3.3 Microecological Changes and Leukocyte Diseases = 499
      • 17.3.4 Infection and Bleeding Disorders = 502
      • 17.4 Treatment of Hematologic Diseases and Infective Microecology = 507
      • 17.4.1 Predisposing Factors and Pathogens = 507
      • 17.4.2 The Principles of Treatment = 509
      • 17.5 Molecular Ecological Treatment = 510
      • 17.5.1 Genic Ecological Treatment = 510
      • 17.5.2 Immune Ecological Treatment = 513
      • References = 515
      • 18 Infectious Microecology in Solid-Organ Transplantation = 519
      • 18.1 Screening of Donor and Recipient Prior to Solid-Organ Transplantation = 520
      • 18.1.1 Donor-Derived Infections = 520
      • 18.1.2 Recipient-Derived Infections = 521
      • 18.2 Timeline of Infection Post-Transplantation = 522
      • 18.2.1 Early Period(1-4 weeks) = 523
      • 18.2.2 Intermediate Period(1-6 months) = 523
      • 18.2.3 Late Period(After 6 months) = 523
      • 18.3 Prevention of Infection in Solid-Organ Transplantation = 524
      • 18.3.1 Viral Infections = 524
      • 18.3.2 Bacterial Infections = 527
      • 18.3.3 Fungal Infections = 528
      • 18.3.4 Parasitic Infections = 530
      • References = 531
      • 19 Microecology of Infections Associated with Surgery and Trauma = 533
      • 19.1 Main Pathogenic Bacteria Associated with Surgical and Trauma-Related Infections = 534
      • 19.1.1 Changes to the Spectrum of the Pathogenic Bacteria = 534
      • 19.1.2 Predominant Pathogenic Bacteria = 538
      • 19.1.3 Primary Pathogenic Factors = 541
      • 19.2 Post-Surgery- and Post-Trauma-Related Wound Infections = 542
      • 19.2.1 Etiology and Pathogenesis of Wound Infections = 543
      • 19.2.2 Prevention and Treatment of Wound Infections = 543
      • 19.3 Intra-Abdominal Infections Associated with Surgery and Trauma = 547
      • 19.3.1 Acute Peritonitis Resulting from Surgery and Trauma = 547
      • 19.3.2 Intra-Abdominal Abscesses after Surgery and Trauma = 549
      • 19.4 Enterogenic Infections Associated with Post-Surgery and Trauma = 550
      • 19.4.1 Intestinal Barrier Function = 551
      • 19.4.2 Intestinal Barrier Function and Bacterial Translocation = 554
      • 19.4.3 Clinical Manifestations of Enterogenic Infections = 556
      • 19.4.4 Prevention and Treatment of Enterogenic Infections = 557
      • 19.5 Prevention and Prognosis of Surgical and Traumatic Infections = 558
      • 19.5.1 Prevention of Post-Surgical and Post-Traumatic Infections = 559
      • 19.5.2 Conventional Treatments Associated with Surgery and Wound Infections = 561
      • 19.5.3 Complications of Severe Surgical and Wound Infections Prevention and Treatment of Sepsis and MOF = 563
      • 19.5.4 Future Directions = 566
      • References = 566
      • 20 Infective Microecology of Chemotherapy and Radiotherapy = 569
      • 20.1 Mechanism of Chemotherapy and Radiotherapy = 569
      • 20.1.1 Chemotherapy = 569
      • 20.1.2 Radiotherapy = 572
      • 20.2 Chemotherapy and Radiotherapy Effect on Microecology = 574
      • 20.2.1 Cancer Patients and Microecology = 574
      • 20.2.2 Microdysbiosis in Cancer Patients = 578
      • 20.3 Microecology of Infection Caused by Radiotherapy and Chemotherapy = 580
      • 20.3.1 Prevention and Treatment of Infection-Related Chemotherapy Toxicity = 581
      • 20.3.2 Prevention and Treatment of Infection-Related Radiotherapy Toxicity = 582
      • 20.3.3 Prevention and Treatment of Cancer Patients Infection = 584
      • 20.3.4 Microecological Control of Cancer Patients = 587
      • 20.4 Prospects = 589
      • References = 590
      • 21 Infectious Microecology in Immunodeficiency Diseases = 593
      • 21.1 HIV, Immune Deficiency, Old View = 594
      • 21.2 Immune Activation in HIV Infection = 595
      • 21.3 Breakdown of Mucosal Immunity = 596
      • 21.4 Solving the Problem from the Microecological Viewpoint = 598
      • 21.5 HIV-1 Infection in Mucosa Scope = 600
      • 21.6 Through Microbiota and Beyond = 601
      • 21.7 Probiotics and HIV = 604
      • References = 605
      • 22 Microecology Intervention in Prevention and Treatment of Infectious Diseases = 611
      • 22.1 Theoretical Basis of Microecological Prevention and Treatment = 611
      • 22.1.1 The Principle of Microecology Balance = 612
      • 22.1.2 Principles of Biological Antagonism = 612
      • 22.1.3 Biological Oxygen Consumption Hypothesis = 613
      • 22.1.4 Immune Activating = 613
      • 22.1.5 Nutritional Effect = 613
      • 22.1.6 Three Circulations Theory = 614
      • 22.1.7 Continuous Succession Effect = 614
      • 22.2 Microecological Modulators = 615
      • 22.2.1 Probiotics Definitions = 615
      • 22.2.2 Characteristics and Classification of Probiotics = 616
      • 22.2.3 Bio-Safety of Probiotics = 617
      • 22.2.4 Bifidobacterium Products = 619
      • 22.2.5 Lactobacillus Products = 620
      • 22.2.6 Bacillus Products = 622
      • 22.2.7 Saccharomyces Preparations = 623
      • 22.2.8 Enterococcus Preparations = 624
      • 22.2.9 Clostridium Butyricum Preparation = 625
      • 22.3 Prebiotics Preparation = 625
      • 22.3.1 Definition = 626
      • 22.3.2 Oligosaccharide as Prebiotics = 627
      • 22.3.3 Physiological Function = 628
      • 22.4 Application of Probiotics and Prebiotics = 631
      • 22.4.1 Gastrointestinal Tract Infection Diseases Prevention = 631
      • 22.4.2 Constipation Treatment = 632
      • 22.4.3 Prevention and Treatment of Hepatic Diseases = 633
      • 22.4.4 Prevention of Hypercholesterolemia = 635
      • 22.4.5 Treatment of Irritable Bowel Syndrome = 635
      • 22.4.6 Prevention and Treatment of Vaginal Infection Diseases = 636
      • 22.4.7 Application in Pediatric Diseases and Infant Care = 636
      • 22.4.8 Application in Antitumor = 637
      • References = 638
      • 23 Future Development of Infectious Microecology = 639
      • 23.1 Evolving View of Infectious Disease = 639
      • 23.2 Advances in Molecular Ecological Techniques = 640
      • 23.3 Normal Human Microbiota = 641
      • 23.4 Interactions between Infectious Diseases and Microbiota = 642
      • 23.4.1 Disturbance of Normal Microbiota by Therapy = 642
      • 23.4.2 Microbiota and Viral Infection = 643
      • 23.4.3 Microbiota and Autoimmunity Disease = 644
      • 23.5 Therapy = 644
      • 23.5.1 Probiotics or Prebiotics = 644
      • 23.5.2 Other Bacteriologic Therapy = 645
      • 23.5.3 The Role of Microbiota in Drug Metabolism = 646
      • 23.6 Summary and Prospects = 646
      • References = 647
      • Index = 649
      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼